Switch View
© BusinessWire
03.11.2025
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclos...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US68621F1021
Organogenesis Holdings Inc
ORGO
LISTED
NASDAQ
Organogenesis Applauds CMS’s Significant Step In Payment Reform
News Preview
With evidence-based portfolio including technologies in each FDA category, we believe we are best positioned in the skin substitutes market for 2026 and beyond With evidence-based portfolio including technologies in each FDA category, we believe we are best positioned in the skin substitutes market for 2026 and beyond...
Themefolio
Profiler
Peergroup
© ActuNews
03.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion beëindigt gesprekken over eerder aangekondigde preklinische overname en zet integratie voort van een strategische klinische speler
News Preview
Leuven, BELGIË, 3 november 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR) een farmaceutische onderaannemingsvennootschap gevestigd in Leuven, maakt bekend dat het de gesprekken heeft beëindigd met betrekking tot de overwogene overname van een vennootschap gespecialiseerd in preklinische microbiologische diensten (zie persbericht...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© ActuNews
03.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion met fin aux discussions relatives à une transaction ciblée en préclinique annoncée précédemment et poursuit l'intégration d'un acteur clinique stratégique
News Preview
Louvain, BELGIQUE – 3 novembre 2025 – 18h00 – Oxurion NV (Euronext Bruxelles : OXUR), société de sous-traitance pharmaceutique basée à Louvain, annonce la fin des discussions relatives à l'acquisition projetée d'une société spécialisée dans les services...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ActuNews
03.11.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ends discussions regarding previously announced preclinical transaction and continues integration of a strategic clinical partner
News Preview
Leuven, BELGIUM, November 3, 2025, 6:00 PM – Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, announces the termination of discussions regarding the planned acquisition of a company specialized in preclinical microbiology services (see press release dated June 19, 2025 – link). Following a thor...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
Metsera Issues Statement in Response to Litigation
News Preview
NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to litigation filed against the Company by Pfizer:
"Pfizer is trying to litigate its way to buying Metsera for a lower price than Nov...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter Health Offers Health Insurance in Iowa in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable
Ambetter Health plans in 58 counties
DES MOINES, Iowa, Nov. 3, 2025/PRNewswire/ -- Ambetter Health, a product...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Informations relatives au nombre total de droits de vote et d’actions
composant le capital...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner
James (Josh) Wilson
Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Cytokinetics To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Cytokinetics betwee...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Baxter To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 in Baxter between February...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.11.2025
ISIN: US74366E1029
Protagonist Therapeutics Inc
PTGX
LISTED
NASDAQ
Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting
News Preview
NEWARK, CALIFORNIA / ACCESS Newswire / November 3, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical data on rusfertide in polycythemia vera, including the Phase 3 VERIFY study, will be the focus of four presentations at the 67th Annual American Society of Hematology (ASH) Annual Meet...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
03.11.2025
ISIN: US52490G1022
Legend Biotech Corp
LEGN
LISTED
NASDAQ
Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
News Preview
Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In MLTX To Contact Him Directly To Discuss Their Options
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In MoonLake To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in MoonLake between March...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QURE
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. On...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from Health Net Offers Health Insurance in California in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter from Health Net plans in 10 counties
SACRAMENTO, Calif., Nov. 3, 2025 /PRNewswire/ -- Ambetter from Health Net, a product offered by Health Net of California (Health Net), a subsidiary of Centene C...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In MOH To Contact Him Directly To Discuss Their Options
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Molina To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Molina between February 5...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LNTH To Contact Him Directly To Discuss Their Options
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lantheus To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $75,000 in Lantheus between Februa...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting
News Preview
Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual Meeting, to be held December 6 – 9, 2025, in Orlando.
"This year’s Incyte presentations highlight the potential of our portfolio to transform the tre...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ATYR To Contact Him Directly To Discuss Their Options
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ATyr To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 in ATyr between January 16, 20...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX CLASS ACTION NOTICE: Berger Montague Encourages MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Class Action
News Preview
PHILADELPHIA, Nov. 3, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company") on behalf of investors who purchased MoonLake shares during the period of March 10, 2024 through September 2...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: KYG1996C1006
CARsgen Therapeutics Holdings Limited
2171
LISTED
HKSE
CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B
News Preview
SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for CT0596, an allogeneic BCMA-targeting CAR-T product candidate developed on its proprietary THANK-u Plus™ platform for rela...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead and Kite Showcase Continued Progress in Transforming Blood Cancer Care With New Cell Therapy Data at ASH 2025
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, will present 21 abstracts, including 5 oral presentations, during the 67th American Society of Hematology (ASH) Annual Meeting and Exposition (December 6-9). These data showcase Kite’s continued progress in transforming blood cancer care and expanding the reach and impact of CAR T-ce...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US7665596034
Rigel Pharmaceuticals, Inc.
RIGL
LISTED
NASDAQ
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
News Preview
Oral presentation to feature updated data from the ongoing Phase 1b study evaluating R289, Rigel's dual IRAK1/4 inhibitor, in patients with relapsed or refractory lower-risk MDS
Four poster presentations will exhibit new REZLIDHIA® (o...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US3741631036
Geron Corp
GERN
LISTED
NASDAQ
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
News Preview
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that five abstracts – one oral and four poster presentations – have been accepted for presentation at the 67th American Society of Hematology (ASH) 2025 Annual Meeting, to be held December 6-...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US3723032062
Genmab A/S
GMAB
LISTED
NASDAQ
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
News Preview
Genmab A/S (Nasdaq: GMAB) today announced that more than 20 abstracts evaluating epcoritamab-bysp, a T-cell engaging bispecific antibody administered subcutaneously, across lines of therapy and B-cell non-Hodgkin’s lymphoma (NHL) subtypes, will be presented at the 67th Annual Meeting and Exposition of the American Society of Hematology (ASH), in O...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US8989201038
TuHURA Biosciences, Inc.
HURA
LISTED
NASDAQ
TuHURA Biosciences Discovery Research on Targeting the Delta Opioid Receptor (DOR) to Reprogram Myeloid-Derived Suppressor Cells (MDSCs) Selected for Oral Presentation at the 67th ASH Annual Meeting and Exposition
News Preview
Oral presentation highlights the first time it's been demonstrated that the DOR is expressed on tumor-associated MDSCs, and that DOR inhibition reprograms multiple mechanisms of MDSC- induced immunosuppression representing a new target in overcoming acquired resistance to cancer immunotherapy...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US0465132068
Atara Biotherapeutics, Inc.
ATRA
LISTED
NASDAQ
Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
News Preview
Tabelecleucel BLA currently under U.S. Food and Drug Administration (FDA) Priority Review
as potentially the first approved therapy in the U.S. for EBV+ PTLD with a Prescription Drug User Fee Act (PDUFA) target action date of January 10, 2026...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform
News Preview
Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx's existing and future AI initiatives
SALT LAKE CITY, Nov. 3, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US03237H1014
Amylyx Pharmaceuticals Inc
AMLX
LISTED
NASDAQ
Amylyx Pharmaceuticals to Present at Upcoming Investor Conferences
News Preview
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that management will present at the following upcoming conferences, which are being conducted in-person:
Guggenheim 2nd Annual Healthcare Innovation Conference: Fireside chat on Monday, November 10, 2025, at 4:30pm ET in Boston, Massachusetts
8th Annual E...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US03940C1009
Arcellx Inc
ACLX
LISTED
NASDAQ
Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition
News Preview
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced it will share two presentations at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition taking place December 6-9, 2025, i...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: KR7475830006
Orum Therapeutics, Inc.
475830
LISTED
KOE
Orum Therapeutics Announces Presentation of Preclinical Data for ORM-1153 at the 2025 American Society of Hematology (ASH) Annual Meeting
News Preview
Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced that preclinical data for ORM-1153, a CD123-targeting DAC with a GSPT1-degrading payload, have been selected for presentation at the upcoming 67th American Society of Hematology (ASH...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter from Peach State Health Plan Offers Health Insurance in Georgia in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable Ambetter from Peach State Health Plan plans in 149 counties
ATLANTA, Nov. 3, 2025 /PRNewswire/ -- Ambetter from Peach State Health Plan, a product offered by a Centene Corporation (NYSE: CNC) company, a l...
Themefolio
Profiler
Peergroup
© BusinessWire
03.11.2025
ISIN: US88033G4073
Tenet Healthcare Corp
THC
LISTED
NYSE
Tenet Announces Private Offerings of Senior Secured Notes and Senior Notes to Refinance $2.0 Billion in Outstanding Notes
News Preview
Tenet Healthcare Corporation (NYSE: THC) today announced private placement offerings of $1.5 billion in aggregate principal amount of new senior secured first lien notes due 2032 (the “first lien notes”) and $0.5 billion in aggregate principal amount of new senior notes due 2033 (the “senior notes” and together with the first lien notes, the “note...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter International, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - BAX
News Preview
NEW YORK, Nov. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX).
Shareholders who...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Lost Money on MoonLake Immunotherapeutics(MLTX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
News Preview
NEW YORK, Nov. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX).
Shareholders...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ATYR
News Preview
NEW YORK, Nov. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR).
Shareholders who purch...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Shareholders that lost money on Savara Inc.(SVRA) should contact The Gross Law Firm about pending Class Action - SVRA
News Preview
NEW YORK, Nov. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased s...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Class Action Filed Against Lantheus Holdings, Inc. (LNTH) Seeking Recovery for Investors - Contact The Gross Law Firm
News Preview
NEW YORK, Nov. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders who...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
The Gross Law Firm Notifies Cytokinetics, Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline - CYTK
News Preview
NEW YORK, Nov. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
News Preview
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
INDIANAPOLIS, Nov. 3, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today plans to build a new $3 billion manufac...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US14149Y1082
Cardinal Health Inc
CAH
LISTED
NYSE
Cardinal Health completes acquisition of Solaris Health
News Preview
Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal Health's MSO platforms to ~3,000 providers in 32 states
DUBLIN, Ohio, Nov. 3, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly plans to build a new €2.6 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
News Preview
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
INDIANAPOLIS, Nov. 3, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today plans to build a new €2.6 billion (3...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US5898891040
Merit Medical Systems Inc
MMSI
LISTED
NASDAQ
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
News Preview
SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced 24-month efficacy findings from the non-randomized AVG cohort of the WAVE trial. Results of the AVG cohort were presented during the Late-Breaking Clinical Trials session at the annual VIVA Fo...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US6024961012
MiMedx Group Inc
MDXG
LISTED
NASDAQ
MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule
News Preview
Company is Well Positioned to Continue to Compete and Grow Company is Well Positioned to Continue to Compete and Grow...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US57055L1070
Marker Therapeutics, Inc.
MRKR
LISTED
NASDAQ
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting
News Preview
Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphomas showed encouraging preliminary efficacy data...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US14070B3096
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel
News Preview
–Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development– ...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US2300311063
Cullinan Therapeutics Inc
CGEM
LISTED
NASDAQ
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
News Preview
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US87164F1057
Syndax Pharmaceuticals Inc
SNDX
LISTED
NASDAQ
Syndax Announces Compelling Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Data Accepted for Presentation at ASH 2025
News Preview
– 12 revumenib and 11 axatilimab abstracts accepted, including 6 oral presentations, underscoring Syndax’s leadership in menin inhibition and CSF-1R inhibition –...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US87164F1057
Syndax Pharmaceuticals Inc
SNDX
LISTED
NASDAQ
Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025
News Preview
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the Company will host an in-person investor event, along with a live webcast, on Monday, December 8, 2025, at 7:00 a.m. ET during the 67th American Society of H...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: IL0011595993
InMode Ltd.
INMD
LISTED
NASDAQ
InMode Appoints Michael Dennison as President of North America
News Preview
IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President of Sales, as President of North America. ...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US45773H4092
Inovio Pharmaceuticals Inc
INO
LISTED
NASDAQ
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
News Preview
Recurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need
INO-3107 previously received Orphan Drug and Breakthrough Therapy designations; BLA submitted under FDA's Acc...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US8808811074
Terns Pharmaceuticals Inc
TERN
LISTED
NASDAQ
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
News Preview
Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient population...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
News Preview
Media ReleaseCOPENHAGEN, Denmark; November 3, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US0197701065
Allogene Therapeutics Inc
ALLO
LISTED
NASDAQ
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
News Preview
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced that a Trial-in-Progress (TIP) poster highlighting the pivotal Phase 2 ALPHA3 tria...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US2210151005
Corvus Pharmaceuticals Inc
CRVS
LISTED
NASDAQ
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition
News Preview
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that final data from its Phase 1/1b trial of soquelitinib in patients with T cell lymphoma will be presented in an oral session at the 67th American Society of Hematology (ASH) Ann...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US00847X1046
Agios Pharmaceuticals Inc
AGIO
LISTED
NASDAQ
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
News Preview
Agios today announced that new data on mitapivat, an oral pyruvate kinase activator, will be featured in oral and poster presentations during ASH...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US74065P1012
Prelude Therapeutics Inc
PRLD
LISTED
NASDAQ
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting
News Preview
WILMINGTON, Del., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced the publication of two abstracts with preclinical data on the Company’s JAK2V617F mutant selective inhibitors and CALR-targeted degrader antibody conjugates...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.11.2025
ISIN: US9032141049
Cogent Biosciences, Inc.
COGT
LISTED
NASDAQ
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results
News Preview
Phase 3 PEAK results in 2nd-line GIST patients expected in November; pivotal APEX results in AdvSM patients expected in December...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Ambetter of Oklahoma Offers Health Insurance in Oklahoma in 2026
News Preview
During open enrollment, starting Nov. 1, residents can access affordable plans from Ambetter of Oklahoma in 43 counties.
OKLAHOMA CITY, Nov. 3, 2025 /PRNewswire/ -- Ambetter of Oklahoma, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare enter...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
